tempesttx.comHealthcareFounded: 1900Funding to Date: $75.2MM
Tempest Therapeutics is a clinical-stage biotechnology company advancing small molecule therapeutics that modulate anti-tumor immunity pathways.
View Enterprise Value for Tempest Therapeutics.